Riverside Company-backed A.forall picks up Provepharm's US generics portfolio
The deal includes four FDA-approved and marketed sterile injectable drugs and two late-stage pipeline assets.
9 September 2025•1 min read
The deal includes four FDA-approved and marketed sterile injectable drugs and two late-stage pipeline assets.
